pipette
ENEnglish

Whole blood transcriptomics atlas across human diseases

Mengzhen Li, Abdülgani Tatar, Emre Green, Ebru Simsek, Çiğdem Yüce Kahraman, Mustafa Ceylan, Fuat Laloğlu, Naci Cevi̇z, Arzu Onder Tatar, Esra Laloğlu, Güngör Akçay, Kenan Çadırcı, Ömer Erkan Yapça, Hilal Kızıltunç Özmen, Turgut Yapanoglu, Özlem Kudaş, Fatma Şimşek, Emsal Pınar Topdağı Yılmaz, Gamze Nur Cimilli Şenocak, Hakan Döneray, Ayse Ozden, Atilla Çayır, Pınar Tosun Taşar, Mustafa Kara, Yunus Emre Aktaş, Mürsel Karadavut, Büşra AKPINAR, Eyup Serhat Calik, B. Erkut, Mufide Akcay, Erdem Karadeniz, Murat Kartal, Esra Dişçi, Mehmet İlhan YILDIRGAN, Sabri Selcuk Atamanalp, Rıfat Peksöz, Yavuz Albayrak, Atilla Eroğlu, Yener Aydın, Sultan Tuna Akgöl GÜR, Mevlana Gul, Erdal Tekin, Ali Bilal Ulaş, Eyüp Şenocak, Ahmet Emre Paksoy, Ayşe Sena Donmez, Mehmet Cenk Turğut, Ozgur Ozmen, Fatih Alper, Hasan Abbas Guliyev y 10 más

Revista con revisión por paresUso en el mundo real

En palabras de los autores

Abstract We present a WBT Atlas, comprising 4444 WBT samples across 98 distinct health conditions, enabling systematic exploration of disease-associated transcriptomic signatures. Health condition–specific profiles are characterized across immune, metabolic, and cell-type specific features at the gene, gene module, and pathway levels. By integrating matched plasma proteomics data from 1280 participants across 28 health conditions, we further assess blood RNA–protein relationships and demonstrate their complementary biological roles. By integrating RNA and protein signatures, we develop multi-class classification models that accurately distinguish among a wide range of health conditions, with integrated models consistently outperforming those based on single-omics data alone. The identified RNA and protein signatures are validated across ten independent WBT cohorts and the UK Biobank. Together, the WBT Atlas provides a genome-wide resource that enables translational discovery in precision medicine.

Resultado principalEl resumen no menciona limitaciones.

Apareció: miércoles, 14 de octubre. Nature Communications. Revista con revisión por pares.

DOI: 10.1038/s41467-026-78440-w